Lido Advisors LLC boosted its position in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 1,243.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 180,590 shares of the company’s stock after acquiring an additional 167,144 shares during the quarter. Lido Advisors LLC’s holdings in BlackRock Capital Allocation Term Trust were worth $2,566,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the company. NewEdge Advisors LLC boosted its position in BlackRock Capital Allocation Term Trust by 4.7% in the third quarter. NewEdge Advisors LLC now owns 16,100 shares of the company’s stock worth $238,000 after purchasing an additional 724 shares during the last quarter. N.E.W. Advisory Services LLC increased its position in shares of BlackRock Capital Allocation Term Trust by 100.0% during the 4th quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after purchasing an additional 1,200 shares during the last quarter. Perennial Investment Advisors LLC lifted its stake in shares of BlackRock Capital Allocation Term Trust by 2.3% in the 3rd quarter. Perennial Investment Advisors LLC now owns 54,867 shares of the company’s stock worth $811,000 after purchasing an additional 1,211 shares during the period. Geneos Wealth Management Inc. lifted its stake in shares of BlackRock Capital Allocation Term Trust by 341.7% in the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after purchasing an additional 1,582 shares during the period. Finally, TD Capital Management LLC boosted its holdings in shares of BlackRock Capital Allocation Term Trust by 5.6% in the third quarter. TD Capital Management LLC now owns 32,007 shares of the company’s stock worth $473,000 after buying an additional 1,699 shares during the last quarter. Institutional investors own 36.12% of the company’s stock.
BlackRock Capital Allocation Term Trust Stock Performance
Shares of NYSE BCAT opened at $15.49 on Monday. BlackRock Capital Allocation Term Trust has a 12-month low of $13.73 and a 12-month high of $15.98. The firm has a 50 day moving average of $15.10 and a 200 day moving average of $14.78.
BlackRock Capital Allocation Term Trust Announces Dividend
BlackRock Capital Allocation Term Trust Company Profile
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
See Also
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
